Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07294924Recruiting

Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements

Role: lead

NCT06002100Enrolling By Invitation

Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements

Role: lead

NCT05996575Completed

Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS

Role: lead

All 3 trials loaded